col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

MDPI AG: Pharmaceuticals
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―10 A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis Jaime Monserrat Villatoro, Gina Mejía-Abril, Lucía Díaz García, Pablo Zubiaur, María Jiménez González, Guillermo Fernandez Jimenez, et al. (+11)
2 [GO] 2021―Dec―27 Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin Joaquim Bosch-Barrera, Ariadna Roqué, Eduard Teixidor, Maria Carmen Carmona-Garcia, Aina Arbusà, Joan Brunet, et al. (+4)
3 [GO] 2021―Dec―27 Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo Otávio Augusto Chaves, Carolina Q. Sacramento, André C. Ferreira, Mayara Mattos, Natalia Fintelman-Rodrigues, Jairo R. Temerozo, et al. (+12)
4 [GO] 2021―Dec―20 Quality Assessment of Investigational Medicinal Products in COVID-19 Clinical Trials: One Year of Activity at the Clinical Trials Office Diego Alejandro Dri, Giulia Praticò, Elisa Gaucci, Carlotta Marianecci, Donatella Gramaglia
5 [GO] 2021―Dec―20 Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach Miroslava Nedyalkova, Mahdi Vasighi, Subrahmanyam Sappati, Anmol Kumar, Sergio Madurga, Vasil Simeonov
6 [GO] 2021―Dec―17 Promising Antiviral Activity of Agrimonia pilosa Phytochemicals against Severe Acute Respiratory Syndrome Coronavirus 2 Supported with In Vivo Mice Study Nashwah G. M. Attallah, Aya H. El-Kadem, Walaa A. Negm, Engy Elekhnawy, Thanaa A. El-Masry, Elshaymaa I. Elmongy, et al. (+4)
7 [GO] 2021―Dec―07 Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives Eugenia Quiros-Roldan, Silvia Amadasi, Isabella Zanella, Melania Degli Antoni, Samuele Storti, Giorgio Tiecco, Francesco Castelli
8 [GO] 2021―Dec―03 Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists Mai Kawazoe, Mari Kihara, Toshihiro Nanki
9 [GO] 2021―Dec―01 Teicoplanin-A New Use for an Old Drug in the COVID-19 Era? Vladimir Vimberg
10 [GO] 2021―Dec―01 Computational and In Vitro Experimental Investigations Reveal Anti-Viral Activity of Licorice and Glycyrrhizin against Severe Acute Respiratory Syndrome Coronavirus 2 Ahmed M. Tolah, Lamya M. Altayeb, Thamir A. Alandijany, Vivek Dhar Dwivedi, Sherif A. El-Kafrawy, Esam I. Azhar
11 [GO] 2021―Dec―01 Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening Raitis Bobrovs, Iveta Kanepe, Nauris Narvaiss, Liene Patetko, Gints Kalnins, Mihails Sisovs, et al. (+8)
12 [GO] 2021―Nov―17 Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines Mohamed Ahmed Attia, Ebtessam Ahmed Essa, Toka Tarek Elebyary, Ahmed Mostafa Faheem, Amal Ali Elkordy
13 [GO] 2021―Nov―12 An Evaluation of the Potential of Essential Oils against SARS-CoV-2 from In Silico Studies through the Systematic Review Using a Chemometric Approach Luiz Torres Neto, Maria Lúcia Guerra Monteiro, Diego Galvan, Carlos Adam Conte-Junior
14 [GO] 2021―Nov―12 Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro Katarzyna Papaj, Patrycja Spychalska, Katarzyna Hopko, Patryk Kapica, Andre Fisher, Markus A. Lill, et al. (+6)
15 [GO] 2021―Nov―09 Regulation of m6A Methylation as a New Therapeutic Option against COVID-19 Carla Zannella, Luca Rinaldi, Giovanni Boccia, Annalisa Chianese, Ferdinando Carlo Sasso, Francesco De Caro, et al. (+2)
16 [GO] 2021―Nov―02 Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication Ilona Bereczki, Henrietta Papp, Anett Kuczmog, Mónika Madai, Veronika Nagy, Attila Agócs, et al. (+15)
17 [GO] 2021―Oct―18 The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19 Horng-Ta Tseng, Xiang-Chi Wu, Chun-Yao Huang, Chun-Ming Shih, Yi-Wen Lin, Feng-Yen Lin
18 [GO] 2021―Oct―18 Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18-30 Years Old): An Independent Post-Marketing Study Abanoub Riad, Andrea Pokorná, Jitka Klugarová, Natália Antalová, Lucia Kantorová, Michal Koščík, Miloslav Klugar
19 [GO] 2021―Oct―18 SARS-CoV-2 Fears Green: The Chlorophyll Catabolite Pheophorbide A Is a Potent Antiviral Guillermo H. Jimenez-Aleman, Victoria Castro, Addis Londaitsbehere, Marta Gutierrez-Rodríguez, Urtzi Garaigorta, Roberto Solano, Pablo Gastaminza
20 [GO] 2021―Oct―18 In Vitro Effect of Taraxacum officinale Leaf Aqueous Extract on the Interaction between ACE2 Cell Surface Receptor and SARS-CoV-2 Spike Protein D614 and Four Mutants Hoai Thi Thu Tran, Michael Gigl, Nguyen Phan Khoi Le, Corinna Dawid, Evelyn Lamy
21 [GO] 2021―Oct―09 Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates Hanah F. Huber, Majid Jaberi-Douraki, Sarah DeVader, Cesar Aparicio-Lopez, Juliet Nava-Chavez, Xuan Xu, et al. (+3)
22 [GO] 2021―Sep―28 Ginkgolic Acid Inhibits Coronavirus Strain 229E Infection of Human Epithelial Lung Cells Maimoona Bhutta, Daniel Sausen, Elisa Gallo, Harel Dahari, Gustavo Doncel, Ronen Borenstein
23 [GO] 2021―Sep―24 Pharmacology and Adverse Events of Emergency-Use Authorized Medication in Moderate to Severe COVID-19 Jen-Yu Hsu, Yan-Chiao Mao, Po-Yu Liu, Kuo-Lung Lai
24 [GO] 2021―Sep―24 A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2) Paolo Coghi, Li Jun Yang, Jerome P. L. Ng, Richard K. Haynes, Maurizio Memo, Alessandra Gianoncelli, et al. (+2)
25 [GO] 2021―Sep―18 Neuropsychiatric Disorders and COVID-19: What We Know So Far Fernanda Majolo, Guilherme Liberato da Silva, Lucas Vieira, Cetin Anli, Luís Fernando Saraiva Macedo Timmers, Stefan Laufer, Márcia Inês Goettert
26 [GO] 2021―Sep―06 In Silico Prediction of Novel Inhibitors of SARS-CoV-2 Main Protease through Structure-Based Virtual Screening and Molecular Dynamic Simulation Sobia Ahsan Halim, Muhammad Waqas, Ajmal Khan, Ahmed Al-Harrasi
27 [GO] 2021―Sep―03 Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds Bruno Rizzuti, Laura Ceballos-Laita, David Ortega-Alarcon, Ana Jimenez-Alesanco, Sonia Vega, Fedora Grande, et al. (+3)
28 [GO] 2021―Sep―01 Synthesis and Biological Evaluation of Honokiol Derivatives Bearing 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3H)-ones as Potential Viral Entry Inhibitors against SARS-CoV-2 Yong Guo, Jie-Ru Meng, Jia-Zheng Liu, Ting Xu, Zhi-Yuan Zheng, Zhi-Hong Jiang, Li-Ping Bai
29 [GO] 2021―Aug―31 Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia Abanoub Riad, Barbora Hocková, Lucia Kantorová, Rastislav Slávik, Lucia Spurná, Adam Stebel, et al. (+2)
30 [GO] 2021―Aug―23 Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic José M. Serra López-Matencio, Manuel Gómez, Esther F. Vicente-Rabaneda, Miguel A. González-Gay, Julio Ancochea, Santos Castañeda
31 [GO] 2021―Aug―23 Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals 2021, 14, 454 Isabella Zanella, Daniela Zizioli, Francesco Castelli, Eugenia Quiros-Roldan
32 [GO] 2021―Aug―18 Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Enrique Ambrocio-Ortiz, Gloria Pérez-Rubio, Alma D. Del Ángel-Pablo, Ivette Buendía-Roldán, Leslie Chávez-Galán, Rafael de Jesús Hernández-Zenteno, et al. (+6)
33 [GO] 2021―Aug―18 Lung Fibrosis after COVID-19: Treatment Prospects Evgeny Bazdyrev, Polina Rusina, Maria Panova, Fedor Novikov, Ivan Grishagin, Vladimir Nebolsin
34 [GO] 2021―Aug―04 Prevalence and Significance of Hypermetabolic Lymph Nodes Detected by 2-[18F]FDG PET/CT after COVID-19 Vaccination: A Systematic Review and a Meta-Analysis Giorgio Treglia, Marco Cuzzocrea, Luca Giovanella, Luigia Elzi, Barbara Muoio
35 [GO] 2021―Aug―02 Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease Swayam Prakash Srivastava, Rohit Srivastava, Subhash Chand, Julie E. Goodwin
36 [GO] 2021―Jul―30 Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study Izabela Nawrot-Hadzik, Mikolaj Zmudziński, Adam Matkowski, Robert Preissner, Małgorzata Kęsik-Brodacka, Jakub Hadzik, et al. (+2)
37 [GO] 2021―Jul―28 Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues Milo Gatti, Eleonora Turrini, Emanuel Raschi, Piero Sestili, Carmela Fimognari
38 [GO] 2021―Jul―28 Antiviral Therapeutic Approaches for SARS-CoV-2 Infection: A Systematic Review Victoria Gil Martínez, Ana Avedillo Salas, Sonia Santander Ballestín
39 [GO] 2021―Jul―19 Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection Gwenolé Loas, Pascal Le Corre
40 [GO] 2021―Jul―19 Soluble Angiotensin Converting Enzyme 2 (ACE2) Is Upregulated and Soluble Endothelial Nitric Oxide Synthase (eNOS) Is Downregulated in COVID-19-induced Acute Respiratory Distress Syndrome (ARDS) Alice G. Vassiliou, Alexandros Zacharis, Chrysi Keskinidou, Edison Jahaj, Maria Pratikaki, Parisis Gallos, et al. (+3)
41 [GO] 2021―Jul―16 Current Status of Baricitinib as a Repurposed Therapy for COVID-19 Maha Saber-Ayad, Sarah Hammoudeh, Eman Abu-Gharbieh, Rifat Hamoudi, Hamadeh Tarazi, Taleb H. Al-Tel, Qutayba Hamid
42 [GO] 2021―Jul―15 Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities Susanna Esposito, Stefano Zona, Andrea Pession, Lorenzo Iughetti, Giovanni Battista Migliori, Nicola Principi
43 [GO] 2021―Jul―12 COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now-New Hopes? Jean Jacques Vanden Eynde
44 [GO] 2021―Jun―23 Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library Prabhat Pratap Singh Tomar, Miriam Krugliak, Isaiah T. Arkin
45 [GO] 2021―Jun―07 Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor Hani A. Alhadrami, Ahmed M. Sayed, Heba Al-Khatabi, Nabil A. Alhakamy, Mostafa E. Rateb
46 [GO] 2021―May―31 Clinical Management of COVID-19: A Review of Pharmacological Treatment Options Ashli M. Heustess, Melissa A. Allard, Dorothea K. Thompson, Pius S. Fasinu
47 [GO] 2021―May―27 Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection Sherif A. El-Kafrawy, Aymn T. Abbas, Sayed S. Sohrab, Ashraf A. Tabll, Ahmed M. Hassan, Naoko Iwata-Yoshikawa, et al. (+2)
48 [GO] 2021―May―26 New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection Bauso Luana Vittoria, Chiara Imbesi, Gasparo Irene, Gabriella Calì, Alessandra Bitto
49 [GO] 2021―May―20 Hydrotalcite-Niclosamide Nanohybrid as OralFormulation towards SARS-CoV-2 Viral Infections Goeun Choi, Huiyan Piao, N. Sanoj Rejinold, Seungjin Yu, Ki yeok Kim, Geun-woo Jin, Jin-Ho Choy
50 [GO] 2021―May―11 Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection Isabella Zanella, Daniela Zizioli, Francesco Castelli, Eugenia Quiros-Roldan
51 [GO] 2021―Apr―26 COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials Zhi-Peng Yan, Ming Yang, Ching-Lung Lai
52 [GO] 2021―Apr―06 Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients Annalisa Noce, Maria Albanese, Giulia Marrone, Manuela Di Lauro, Anna Pietroboni Zaitseva, Daniela Palazzetti, et al. (+9)
53 [GO] 2021―Apr―06 Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods Tiziana Ginex, Urtzi Garaigorta, David Ramírez, Victoria Castro, Vanesa Nozal, Inés Maestro, et al. (+5)
54 [GO] 2021―Mar―31 Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids Gill Diamond, Natalia Molchanova, Claudine Herlan, John A. Fortkort, Jennifer S. Lin, Erika Figgins, et al. (+6)
55 [GO] 2021―Mar―08 Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study Gil Darquennes, Pascal Le Corre, Olivier Le Moine, Gwenolé Loas
56 [GO] 2021―Mar―05 Rapamycin: Drug Repurposing in SARS-CoV-2 Infection Jiri Patocka, Kamil Kuca, Patrik Oleksak, Eugenie Nepovimova, Martin Valis, Michal Novotny, Blanka Klimova
57 [GO] 2021―Mar―05 Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches Hossam M. Abdallah, Ali M. El-Halawany, Alaa Sirwi, Amr M. El-Araby, Gamal A. Mohamed, Sabrin R. M. Ibrahim, et al. (+4)
58 [GO] 2021―Feb―25 Evaluation of the Antiviral Activity of Sitagliptin-Glatiramer Acetate Nano-Conjugates against SARS-CoV-2 Virus Nabil A. Alhakamy, Osama A. A. Ahmed, Tarek S. Ibrahim, Hibah M. Aldawsari, Khalid Eljaaly, Usama A. Fahmy, et al. (+3)
59 [GO] 2021―Jan―25 Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach Andrea Gelemanović, Tinka Vidović, Višnja Stepanić, Katarina Trajković
60 [GO] 2021―Jan―20 COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection Katarzyna Kotfis, Kacper Lechowicz, Sylwester Drożdżal, Paulina Niedźwiedzka-Rystwej, Tomasz K. Wojdacz, Ewelina Grywalska, et al. (+3)
61 [GO] 2021―Jan―11 Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection Praveen P. N. Rao, Amy Trinh Pham, Arash Shakeri, Amna El Shatshat, Yusheng Zhao, Rahul C. Karuturi, Ahmed A. Hefny
62 [GO] 2021―Jan―07 Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2 Iman Almansour, Nabela Calamata Macadato, Thamer Alshammari
63 [GO] 2020―Dec―28 Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19 Cara A. Timpani, Emma Rybalka
64 [GO] 2020―Dec―08 Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules Kenana Al Adem, Aya Shanti, Cesare Stefanini, Sungmun Lee
65 [GO] 2020―Dec―04 FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2 Ahmed Mostafa, Ahmed Kandeil, Yaseen A. M. M. Elshaier, Omnia Kutkat, Yassmin Moatasim, Adel A. Rashad, et al. (+14)
66 [GO] 2020―Nov―28 Emetine Is Not Ipecac: Considerations for Its Use as Treatment for SARS-CoV2 Martin D. Bleasel, Gregory M. Peterson
67 [GO] 2020―Nov―27 Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics Anna Maria Piras, Ylenia Zambito, Maurizio Lugli, Baldassare Ferro, Paolo Roncucci, Filippo Mori, et al. (+4)
68 [GO] 2020―Nov―10 Role of 2-[18F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review Salvatore Annunziata, Roberto C. Delgado Bolton, Christel-Hermann Kamani, John O. Prior, Domenico Albano, Francesco Bertagna, Giorgio Treglia
69 [GO] 2020―Oct―17 Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study Benjamin Rossi, Lee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, et al. (+7)
70 [GO] 2020―Oct―16 Medicinal Plants to Strengthen Immunity during a Pandemic Olga Babich, Stanislav Sukhikh, Alexander Prosekov, Lyudmila Asyakina, Svetlana Ivanova
71 [GO] 2020―Sep―09 Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk? Cristina Müller, Roger Schibli, Britta Maurer
72 [GO] 2020―Sep―01 Zinc(II)-The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19? Aleksandra Hecel, Małgorzata Ostrowska, Kamila Stokowa-Sołtys, Joanna Wątły, Dorota Dudek, Adriana Miller, et al. (+5)
73 [GO] 2020―Aug―10 Emerging Therapeutic Modalities against COVID-19 Shipra Malik, Anisha Gupta, Xiaobo Zhong, Theodore P. Rasmussen, Jose E. Manautou, Raman Bahal
74 [GO] 2020―Jul―28 Squalene Emulsion Manufacturing Process Scale-Up for Enhanced Global Pandemic Response Tony Phan, Christian Devine, Erik D. Laursen, Adrian Simpson, Aaron Kahn, Amit P. Khandhar, et al. (+5)
75 [GO] 2020―Jul―27 Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence? Mikhail Kiselevskiy, Irina Shubina, Irina Chikileva, Suria Sitdikova, Igor Samoylenko, Natalia Anisimova, et al. (+4)
76 [GO] 2020―Jul―20 Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications Yufeng Wei, Rameen Shah
77 [GO] 2020―Jul―06 Cancer Patients Have a Higher Risk Regarding COVID-19 - and Vice Versa? Franz Geisslinger, Angelika M. Vollmar, Karin Bartel
78 [GO] 2020―Jun―25 Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection Andreia Palmeira, Emília Sousa, Aylin Köseler, Ramazan Sabirli, Tarık Gören, İbrahim Türkçüer, et al. (+3)
79 [GO] 2020―May―14 The Rationale for Potential Pharmacotherapy of COVID-19 Maha Saber-Ayad, Mohamed A. Saleh, Eman Abu-Gharbieh
80 [GO] 2020―May―14 COVID-19: An Update About the Discovery Clinical Trial Jean Jacques Vanden Eynde
81 [GO] 2020―Apr―13 COVID-19: A Brief Overview of the Discovery Clinical Trial Jean Jacques Vanden Eynde
82 [GO] 2020―Mar―23 Emetine, Ipecac, Ipecac Alkaloids and Analogues as Potential Antiviral Agents for Coronaviruses Martin D Bleasel, Gregory M Peterson


[de][en]

Last change 2022―Jan―20 20:43:25 UTC

© Daten-Quadrat 2022       Done in 0.008 sec